The benefits of tirzepatide beyond weight loss include improvements in blood sugar control, cardiovascular markers, blood pressure, and potentially anti-inflammatory effects
Personalized GLP-1 Therapy: A Genetics-Driven Alternative The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) variants that relate to GLP-1 and related signaling pathways
Higher-dose formulations of semaglutide (Wegovy, 2.4 mg weekly) and tirzepatide (Zepbound, up to 15 mg weekly) are approved specifically for chronic weight management in non-diabetic patients
ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate
This reduces reliance on static historical trends and enables faster scenario testing
Stacking it with supportive compounds like CLA creates a synergistic fat-burning and energy-support effect